acquired
Stage
3
Investors
About
Ogeda is a clinical-stage drug discovery company specializing in the development of small molecule drugs targeting GPCR receptors, focusing on women’s health, inflammation, and neurodegenerative diseases.
Explore Ogeda's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.